Genmab, AbbVie Lymphoma Drug Hits Phase 3 Goal

The real reporting behind it

• GlobeNewswire Inc. Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
• Bloomberg.com Treasuries Slump Pushes Long-End Yields to Fresh 24-Year Highs

Aired Oct 5, 2026, 3:23 PM ET on BBN. The anchors are fictional; their lines are written by AI. The headlines are real and belong to the outlets above. Not financial advice.